Cytokines in dermatology-A basic overview

Indian Journal of Dermatology

Volumn 56, Issue 4, 2011, Pages 368-374

  Coondoo, Arijit ^a  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Cutaneous tissues; cytokines; signaling molecules

Indexed keywords

CHEMOKINE RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; ERYTHROPOIETIN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 19; INTERLEUKIN 2; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 24; INTERLEUKIN 26; INTERLEUKIN 32; INTERLEUKIN 33; INTERLEUKIN 4; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR; UNINDEXED DRUG;

APOPTOSIS; CELL ACTIVATION; CELL COMMUNICATION; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; DERMATOLOGY; HEMATOPOIESIS; HUMAN; IMMUNITY; INFLAMMATION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 80052910960     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.84717     Document Type: Review

References (57)

1. Holman DM, Kalaaji AN. Cytokines in dermatology. J Drugs Dermatol 2006;5:520-4.
2. Williams IR, Rich BE, Kupper TS. Cytokines. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's Dermatology in General Medicine. 7 th ed. New York: McGraw-Hill; 2008. p. 115-26.
3. Trefzer U, Hofmann M, Sterry W, Asadullah K. Cytokine and anticytokine therapy in dermatology. Expert Opin Biol Ther 2003;3:733-43. (Pubitemid 36934973)
4. Grunnet LG, Mandrup-Poulsen T. Cytokines and Type 1 Diabetes: A numbers game. Diabetes 2011;60:697-9.
5. Feliciani C, Gupta AK, Saucier DN. Keratinocytes and Cytokine/growth factors. Crit Rev Oral Biol Med 1996;7:300-18. (Pubitemid 27010029)
6. Ihle JN. Cytokine receptor signaling. Nature 1995;377:591-4.
7. Ozaki K, Leonard WJ. Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem 2002;277:29355-8. (Pubitemid 41079217)
8. Oppenheim JJ. Cytokines: Past, present and future. Int J Haematol 2001;74:3-8.
9. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway. Biochem J 1998;334:297-314. (Pubitemid 28448572)
10. Wormald S, Hilton DJ. Inhibitors of cytokine signal transduction. J Biol Chem 2004;279:821-4. (Pubitemid 38082600)
11. Moynagh PN. The NF-kB pathway. J Cell Sci 2005;118:4589-92.
12. Miyasaka N. Introduction: Cytokine receptors and their classification. Nippon Rinsho 2005;63 Suppl 8:5-9.
13. Liongue C, Ward AC. Evolution of Class I cytokine receptors. BMC Evol Biol 2007;7:120.
14. Tanaka M, Miyajima A. Classification of cytokine receptor superfamily and signal transduction-structural feature and functional property. Nippon Rinsho 1998;56:1784-90.
15. Kupper TS. Immune and inflammatory responses in cutaneous tissues Mechanisms and speculations. J Clin Invest 1990;86:1783.
16. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011;117:3720-32.
17. Murphy JE, Robert C, Kupper TS. Interleukin-1 and cutaneous inflammation: A crucial link between innate and acquired immunity. J Invest Dermatol 2000;114:602-8. (Pubitemid 30415356)
18. Raychaudhuri SP, Jiang WY, Raychaudhuri SK. Revisiting the Koebner Phenomenon: Role of NGF and its receptor system in the pathogenesis of psoriasis. Am J Pathol 2008;172:961-71. (Pubitemid 351519993)
19. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008;223:20-38. (Pubitemid 351986169)
20. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003;73:213-24. (Pubitemid 36158296)
21. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479-90. (Pubitemid 41587888)
22. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001;104:487-501. (Pubitemid 32201945)
23. Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 2003;66:1403-8. (Pubitemid 38373326)
24. Tang P, Hung M-C, Klostergaard J. Human pro-tumor necrosis factor is a homotrimer. Biochemistry 1996;35:82116-25.
25. Cordoro KM, Feldman SR. TNFα inhibitors in dermatology. Skin Therapy Letter 2007;12:4-6.
26. Marzec M, Halasa K, Kasprzycka M, Wysocka M, Liu X, Tobias JW, et al. Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on cd4+ cutaneous t-cell lymphoma cells. Cancer Res 2008;68:1083-91. (Pubitemid 351272226)
27. Rautajoki KJ, Marttila EM, Nyman TA, Lahesmaa R. Interleukin-4 inhibits caspase-3 by regulating several proteins in the Fas pathway during initial stages of human T helper 2 cell differentiation. Mol Cell Proteomics 2007;6:238-51. (Pubitemid 46359513)
28. Itakura A, Kikuchi Y, Kouro T, Ikutani M, Takaki S, Askenase PW, et al. Interleukin 5 Plays an essential role in elicitation of contact sensitivity through dual effects on eosinophils and B-1 cells. Int Arch Allergy Immunol 2006;140 (Suppl 1):8-16. (Pubitemid 43882379)
29. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J 2003;374:1-20. (Pubitemid 37046923)
30. Asadullah K, Sabat R, Friedrich M, Volk HD, Sterry W. Interleukin-10: An important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy 2004;3:185-92. (Pubitemid 38832749)
31. Conti P, Kempuraj D, Frydas S, Kandere K, Boucher W, Letourneau R, et al. IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26. Immunol Lett 2003;88:171-4. (Pubitemid 36993682)
32. Rich BE, Kupper TS. Cytokines: IL-20-a new effector in skin inflammation. Curr Biol 2001;11:R531-4. (Pubitemid 32632712)
33. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003;3:133-46. (Pubitemid 37328691)
34. Lankford CS, Frucht DM. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003;73:49-56. (Pubitemid 36125674)
35. Morishima N, Mizoguchi I, Okumura MA, Chiba Y, Xu M, Shimizu M, et al. A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes. J Biomed Biotechnol 2010;2010:605483.
36. van Beelen AJ, Teunissen, M, Kapsenberg ML, de Jong EC. Interleukin 17 in inflammatory skin disorders. Curr Opin Allergy Clin Immunol 2007;7:374-81.
37. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: A cytokine and inducer of TNFalpha Immunity 2005;22:131-42.
38. Kontsek P, Karayianni-Vasconcelos G, Kontseková E. The human interferon system: characterization and classification after discovery of novel members. Acta Virol 2003;47:201-15. (Pubitemid 38186083)
39. Theofilopoulos AN, Baccala R, Beutler R, Kono DH. Type I interferons (α/β) in immunity and autoimmunity. Annu Rev Immunol 2005;23:307-36.
40. Zuniga EI, Hahm B, Oldstone MB. Type I interferon during viral infections: Multiple triggers for a multifunctional mediator. Curr Top Microbiol Immunol 2007;316:337-57.
41. Bogdan C. The function of Type 1 interferons in antimicrobial immunity. Curr Opin Immunol 2000;12;419-24. (Pubitemid 30410347)
42. Bogdan C, Mattner J, Schleicher U. The role of type I interferons in non-viral infections. Immunol Rev 2004;202:33-48. (Pubitemid 39576903)
43. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: An overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163-89. (Pubitemid 38174573)
44. Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, Hartmann R. Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol 2007;81:7749-58. (Pubitemid 47047861)
45. Derynck R. Transforming growth factor alpha. Cell 1988;54:593-5.
46. Blobe GC, Schiemann WP, Lodish HF. Role of Transforming Growth Factor β in Human Disease. N Engl J Med 2000;342:1350-8. (Pubitemid 30408720)
47. Laing KJ, Secombes CJ. Chemokines. Dev Comp Immunol 2004;28:443-60. (Pubitemid 38177447)
48. Roda JM, Parihar R, Magro C, Nuovo GJ, Tridandapani S, Carson WE 3 rd. Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer Res 2006;66:517-26. (Pubitemid 43166061)
49. Megjugorac NJ, Young HA, Amrute SB, Olshalsky SL, Fitzgerald-Bocarsly P. Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells. J Leukoc Biol 2004;75:504-14. (Pubitemid 38316382)
50. Fernandez EJ, Lolis E. Structure, Function and Inhibition of chemokines. Ann Rev Pharmacol Toxicol 2002;42:469-99.
51. Zhlotnik A, Yoshie O. Chemokines: A new classification system and their role in immunity. Immunity 2000;12:121-7. (Pubitemid 30398626)
52. Strieter RM, Belperio JA, Burdick MD, Keane MP. CXC chemokines in angiogenesis relevant to chronic fibroproliferation. Curr Drug Targets Inflamm Allergy 2005;4:23-6. (Pubitemid 40590030)
53. Laing K, Secombes C. Chemokines. Dev Comp Immunol 2004:28:443-60. (Pubitemid 38177447)
54. Umehara H, Goda S, Imai T, Nagano Y, Minami Y, Tanaka Y, et al. Fractalkine, a CX3C-chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP-1. Immunol Cell Biol 2001;79:298-302. (Pubitemid 32522179)
55. Cerdan C, Serfling E, Olive D. The C-class chemokine, lymphotactin, impairs the induction of Th1-type lymphokines in human CD4+ T cells. Blood 2000;96:420-8. (Pubitemid 30463358)
56. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000;95:3032-43. (Pubitemid 30321151)
57. Curnock AP, Logan MK, Ward SG. Chemokine signaling: Pivoting around multiple phosphoinositide 3-kinases. Immunology 2002;105:125-36. (Pubitemid 34146678)